124
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

An Analysis of Preoperative Inflammatory Indicators That Influence the Drainage Tube Retention Time in Patients with Breast Cancer Surgery

, , , , & ORCID Icon
Pages 91-103 | Received 02 Nov 2023, Accepted 27 Feb 2024, Published online: 05 Mar 2024

References

  • Li N, Deng Y, Zhou L, et al. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017. J Hematol Oncol. 2019;12(1):140. PMID: 31864424; PMCID: PMC6925497. doi:10.1186/s13045-019-0828-0
  • Radecka B, Litwiniuk M. Breast cancer in young women. Ginekol Pol. 2016;87(9):659–663. PMID: 27723074. doi:10.5603/GP.2016.0062
  • Shien T, Iwata H. Adjuvant and neoadjuvant therapy for breast cancer. Jpn J Clin Oncol. 2020;50(3):225–229. PMID: 32147701. doi:10.1093/jjco/hyz213
  • Chen CF, Lin SF, Hung CF, Chou P. Risk of infection is associated more with drain duration than daily drainage volume in prosthesis-based breast reconstruction: a cohort study. Medicine. 2016;95(49):e5605. PMID: 27930584; PMCID: PMC5266056. doi:10.1097/MD.0000000000005605
  • Héquet D, Huchon C, Baffert S, et al. Preoperative clinical pathway of breast cancer patients: determinants of compliance with EUSOMA quality indicators. Br J Cancer. 2017;116(11):1394–1401. PMID: 28441385; PMCID: PMC5520093. doi:10.1038/bjc.2017.114
  • Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. PMID: 18650914. doi:10.1038/nature07205
  • Borsig L, Wolf MJ, Roblek M, Lorentzen A, Heikenwalder M. Inflammatory chemokines and metastasis--tracing the accessory. Oncogene. 2014;33(25):3217–3224. Epub 2013 Jul 15. PMID: 23851506. doi:10.1038/onc.2013.272
  • Dong X, Liu C, Yuan J, et al. Prognostic roles of neutrophil-to-lymphocyte ratio and stromal tumor-infiltrating lymphocytes and their relationship in locally advanced triple-negative breast cancer treated with neoadjuvant chemotherapy. Breast Care. 2021;16(4):328–334. PMID: 34602938; PMCID: PMC8436630. doi:10.1159/000509498
  • Morrison L, Laukkanen JA, Ronkainen K, Kurl S, Kauhanen J, Toriola AT. Inflammatory biomarker score and cancer: a population-based prospective cohort study. BMC Cancer. 2016;16:80. PMID: 26860264; PMCID: PMC4748611. doi:10.1186/s12885-016-2115-6
  • Xu M, Chen R, Liu L, et al. Systemic immune-inflammation index and incident cardiovascular diseases among middle-aged and elderly Chinese adults: the Dongfeng-Tongji cohort study. Atherosclerosis. 2021;323:20–29. PMID: 33773161. doi:10.1016/j.atherosclerosis.2021.02.012
  • Browne JP, Jeevan R, Gulliver-Clarke C, Pereira J, Caddy CM, van der Meulen JHP. The association between complications and quality of life after mastectomy and breast reconstruction for breast cancer. Cancer. 2017;123(18):3460–3467. Epub 2017 May 17. PMID: 28513834. doi:10.1002/cncr.30788
  • Yfantis A, Sarafis P, Moisoglou I, et al. How breast cancer treatments affect the quality of life of women with non-metastatic breast cancer one year after surgical treatment: a cross-sectional study in Greece. BMC Surg. 2020;20(1):210. PMID: 32957940; PMCID: PMC7507267. doi:10.1186/s12893-020-00871-z
  • Wang Z, Han X. Clinical significance of breast-conserving surgery for early breast cancer and its impact on patient life quality of life. J BUON. 2019;24(5):1898–1904. PMID: 31786853.
  • Palve JS, Luukkaala TH, Kääriäinen MT. Predictive risk factors of complications in different breast reconstruction methods. Breast Cancer Res Treat. 2020;182(2):345–354. Epub 2020 May 28. PMID: 32468337; PMCID: PMC7297836. doi:10.1007/s10549-020-05705-3
  • Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–867. PMID: 12490959; PMCID: PMC2803035. doi:10.1038/nature01322
  • Chen D, Zhang X, Li Z, Zhu B. Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages. Theranostics. 2021;11(3):1016–1030. PMID: 33391518; PMCID: PMC7738889. doi:10.7150/thno.51777
  • Li Y, Shao Y, Bai L, Zhou X. Increased derived neutrophil-to-lymphocyte ratio and breast imaging-reporting and data system classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy. Cancer Manag Res. 2018;10:3841–3847. PMID: 30288115; PMCID: PMC6161733. doi:10.2147/CMAR.S174537
  • Chen L, Kong X, Wang Z, Wang X, Fang Y, Wang J. Pretreatment systemic inflammation response index in patients with breast cancer treated with neoadjuvant chemotherapy as a useful prognostic indicator. Cancer Manag Res. 2020;12:1543–1567. PMID: 32184659; PMCID: PMC7060771. doi:10.2147/CMAR.S235519
  • Zhang Y, Sun Y, Zhang Q. Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis. Cancer Cell Int. 2020;20:224. PMID: 32528232; PMCID: PMC7282128. doi:10.1186/s12935-020-01308-6
  • Hua X, Long ZQ, Huang X, et al. The Value of Prognostic Nutritional Index (PNI) in predicting survival and guiding radiotherapy of patients with T1-2N1 breast cancer. Front Oncol. 2020;9:1562. PMID: 32083015; PMCID: PMC7002465. doi:10.3389/fonc.2019.01562
  • Sasaki M, Miyoshi N, Fujino S, et al. The geriatric nutritional risk index predicts postoperative complications and prognosis in elderly patients with colorectal cancer after curative surgery. Sci Rep. 2020;10(1):10744. PMID: 32612136; PMCID: PMC7329855. doi:10.1038/s41598-020-67285-y
  • Huang L, Mo Z, Zhang L, Qin S, Qin S, Li S. Diagnostic value of albumin to fibrinogen ratio in cervical cancer. Int J Biol Markers. 2020;35(2):66–73. Epub 2020 May 11. PMID: 32389031. doi:10.1177/1724600820915916
  • Guo Y, Shi D, Zhang J, et al. The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) score is a novel significant prognostic factor for patients with metastatic prostate cancer undergoing cytoreductive radical prostatectomy. J Cancer. 2019;10(1):81–91. PMID: 30662528; PMCID: PMC6329846. doi:10.7150/jca.27210
  • Ahiko Y, Shida D, Horie T, et al. Controlling nutritional status (CONUT) score as a preoperative risk assessment index for older patients with colorectal cancer. BMC Cancer. 2019;19(1):946. PMID: 31690275; PMCID: PMC6833132. doi:10.1186/s12885-019-6218-8
  • Sagou K, Ozeki K, Ukai S, Adachi Y, Fukushima N, Kohno A. Impact of a nutritional risk index on clinical outcomes after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2019;25(11):2287–2296. Epub 2019 Jul 5. PMID: 31284071. doi:10.1016/j.bbmt.2019.07.002
  • Van de Sande L, Cosyns S, Willaert W, Ceelen W. Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review. Drug Deliv. 2020;27(1):40–53. PMID: 31858848; PMCID: PMC6968566. doi:10.1080/10717544.2019.1704945
  • Hoogenboezem EN, Duvall CL. Harnessing albumin as a carrier for cancer therapies. Adv Drug Deliv Rev. 2018;130:73–89. Epub 2018 Jul 27. PMID: 30012492; PMCID: PMC6200408. doi:10.1016/j.addr.2018.07.011
  • Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER, Slingerland JM. Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention. CA Cancer J Clin. 2017;67(5):378–397. Epub 2017 Aug 1. PMID: 28763097; PMCID: PMC5591063. doi:10.3322/caac.21405
  • Lin W, Yang Y, Zhong W, et al. The effect of low and high vacuum drainage on the postoperative drainage of breast cancer: insights from a prospective, non-inferiority, randomized clinical trial. Cancer Manag Res. 2020;12:12487–12496. PMID: 33299355; PMCID: PMC7721110. doi:10.2147/CMAR.S283031
  • Matusiak D, Wichtowski M, Pieszko K, Kobylarek D, Murawa D. Is negative-pressure wound therapy beneficial in modern-day breast surgery? Contemp Oncol. 2019;23(2):69–73. Epub 2019 May 27. PMID: 31316287; PMCID: PMC6630394. doi:10.5114/wo.2019.85199